FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Roivant Sciences Ltd. Stock AnalysisComprehensive stock analysis for Roivant Sciences Ltd. (ROIV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisROIV
ROIV
Roivant Sciences Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ROIV
Home🔹Stocks🔹Roivant Sciences Ltd.

Roivant Sciences Ltd.

ROIV•NASDAQ

Roivant Sciences Ltd.

ROIV•NASDAQ
Market cap
$24.34B
Sentiment

Your view on ROIV

Mkt Cap
$24.34B
Sentiment
Your view
ROIV
Roivant Sciences Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ROIV
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Roivant Sciences Ltd.

Industry
Biotechnology
Sector
Healthcare
CEO
Matthew Gline
Headquarters
11-12 St. James's Square, London, GB
Industry
Biotechnology
Sector
Healthcare
CEO
Matthew Gline
Headquarters
11-12 St. James's Square, London, GB
Description

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News